Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
HCV entry into cells is a multi-step and slow process. It is believed that the initial capture of HCV particles by glycosaminoglycans and/or lipoprotein receptors is followed by coordinated interactions with the scavenger receptor class B type I (SR-BI), a major receptor of high-density lipoprotein...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2009
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/027cb94bbee944f3a4f16bf91f9e8daa |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:027cb94bbee944f3a4f16bf91f9e8daa |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:027cb94bbee944f3a4f16bf91f9e8daa2021-11-25T05:47:16ZReceptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.1553-73661553-737410.1371/journal.ppat.1000310https://doaj.org/article/027cb94bbee944f3a4f16bf91f9e8daa2009-02-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19229312/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374HCV entry into cells is a multi-step and slow process. It is believed that the initial capture of HCV particles by glycosaminoglycans and/or lipoprotein receptors is followed by coordinated interactions with the scavenger receptor class B type I (SR-BI), a major receptor of high-density lipoprotein (HDL), the CD81 tetraspanin, and the tight junction protein Claudin-1, ultimately leading to uptake and cellular penetration of HCV via low-pH endosomes. Several reports have indicated that HDL promotes HCV entry through interaction with SR-BI. This pathway remains largely elusive, although it was shown that HDL neither associates with HCV particles nor modulates HCV binding to SR-BI. In contrast to CD81 and Claudin-1, the importance of SR-BI has only been addressed indirectly because of lack of cells in which functional complementation assays with mutant receptors could be performed. Here we identified for the first time two cell types that supported HCVpp and HCVcc entry upon ectopic SR-BI expression. Remarkably, the undetectable expression of SR-BI in rat hepatoma cells allowed unambiguous investigation of human SR-BI functions during HCV entry. By expressing different SR-BI mutants in either cell line, our results revealed features of SR-BI intracellular domains that influence HCV infectivity without affecting receptor binding and stimulation of HCV entry induced by HDL/SR-BI interaction. Conversely, we identified positions of SR-BI ectodomain that, by altering HCV binding, inhibit entry. Finally, we characterized alternative ectodomain determinants that, by reducing SR-BI cholesterol uptake and efflux functions, abolish HDL-mediated infection-enhancement. Altogether, we demonstrate that SR-BI is an essential HCV entry factor. Moreover, our results highlight specific SR-BI determinants required during HCV entry and physiological lipid transfer functions hijacked by HCV to favor infection.Marlène DreuxViet Loan Dao ThiJudith FresquetMaryse GuérinZélie JuliaGéraldine VerneyDavid DurantelFabien ZoulimDimitri LavilletteFrançois-Loïc CossetBirke BartoschPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 5, Iss 2, p e1000310 (2009) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
| spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Marlène Dreux Viet Loan Dao Thi Judith Fresquet Maryse Guérin Zélie Julia Géraldine Verney David Durantel Fabien Zoulim Dimitri Lavillette François-Loïc Cosset Birke Bartosch Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. |
| description |
HCV entry into cells is a multi-step and slow process. It is believed that the initial capture of HCV particles by glycosaminoglycans and/or lipoprotein receptors is followed by coordinated interactions with the scavenger receptor class B type I (SR-BI), a major receptor of high-density lipoprotein (HDL), the CD81 tetraspanin, and the tight junction protein Claudin-1, ultimately leading to uptake and cellular penetration of HCV via low-pH endosomes. Several reports have indicated that HDL promotes HCV entry through interaction with SR-BI. This pathway remains largely elusive, although it was shown that HDL neither associates with HCV particles nor modulates HCV binding to SR-BI. In contrast to CD81 and Claudin-1, the importance of SR-BI has only been addressed indirectly because of lack of cells in which functional complementation assays with mutant receptors could be performed. Here we identified for the first time two cell types that supported HCVpp and HCVcc entry upon ectopic SR-BI expression. Remarkably, the undetectable expression of SR-BI in rat hepatoma cells allowed unambiguous investigation of human SR-BI functions during HCV entry. By expressing different SR-BI mutants in either cell line, our results revealed features of SR-BI intracellular domains that influence HCV infectivity without affecting receptor binding and stimulation of HCV entry induced by HDL/SR-BI interaction. Conversely, we identified positions of SR-BI ectodomain that, by altering HCV binding, inhibit entry. Finally, we characterized alternative ectodomain determinants that, by reducing SR-BI cholesterol uptake and efflux functions, abolish HDL-mediated infection-enhancement. Altogether, we demonstrate that SR-BI is an essential HCV entry factor. Moreover, our results highlight specific SR-BI determinants required during HCV entry and physiological lipid transfer functions hijacked by HCV to favor infection. |
| format |
article |
| author |
Marlène Dreux Viet Loan Dao Thi Judith Fresquet Maryse Guérin Zélie Julia Géraldine Verney David Durantel Fabien Zoulim Dimitri Lavillette François-Loïc Cosset Birke Bartosch |
| author_facet |
Marlène Dreux Viet Loan Dao Thi Judith Fresquet Maryse Guérin Zélie Julia Géraldine Verney David Durantel Fabien Zoulim Dimitri Lavillette François-Loïc Cosset Birke Bartosch |
| author_sort |
Marlène Dreux |
| title |
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. |
| title_short |
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. |
| title_full |
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. |
| title_fullStr |
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. |
| title_full_unstemmed |
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. |
| title_sort |
receptor complementation and mutagenesis reveal sr-bi as an essential hcv entry factor and functionally imply its intra- and extra-cellular domains. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2009 |
| url |
https://doaj.org/article/027cb94bbee944f3a4f16bf91f9e8daa |
| work_keys_str_mv |
AT marlenedreux receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT vietloandaothi receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT judithfresquet receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT maryseguerin receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT zeliejulia receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT geraldineverney receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT daviddurantel receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT fabienzoulim receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT dimitrilavillette receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT francoisloiccosset receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains AT birkebartosch receptorcomplementationandmutagenesisrevealsrbiasanessentialhcventryfactorandfunctionallyimplyitsintraandextracellulardomains |
| _version_ |
1718414440133558272 |